🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 20 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/12/1992 37,43 37,43 37,43 37,43 +0,00% 0,00% 267
24/12/1992 37,43 37,43 37,43 37,43 -4,76% 0,00% 347
23/12/1992 39,30 39,30 37,43 39,30 +0,00% 4,76% 6.305
22/12/1992 36,49 39,30 36,49 39,30 +0,00% 7,69% 20.278
21/12/1992 37,43 40,24 36,49 39,30 +2,44% 10,00% 29.388
18/12/1992 38,37 40,24 38,37 38,37 -4,65% 4,88% 30.724
17/12/1992 42,11 42,11 39,30 40,24 +0,00% 6,67% 4.943
16/12/1992 41,17 43,04 40,24 40,24 -2,27% 6,82% 33.316
15/12/1992 41,17 43,04 41,17 41,17 +0,00% 4,55% 7.160
14/12/1992 43,04 43,04 41,17 41,17 +0,00% 4,35% 2.511
11/12/1992 43,04 43,04 41,17 41,17 +0,00% 4,35% 31.873
10/12/1992 41,17 43,04 41,17 41,17 +0,00% 4,55% 68.154
09/12/1992 43,04 43,04 41,17 41,17 +0,00% 4,35% 19.129
08/12/1992 41,17 43,04 41,17 41,17 +0,00% 4,55% 47.476
07/12/1992 43,04 43,04 41,17 41,17 -1,12% 4,35% 33.209
04/12/1992 41,17 43,04 41,17 41,64 +1,14% 4,55% 23.671
03/12/1992 43,04 43,04 41,17 41,17 -2,22% 4,35% 33.636
02/12/1992 42,11 43,98 42,11 42,11 +0,00% 4,44% 27.385
01/12/1992 45,85 46,79 42,11 42,11 -4,26% 10,20% 99.306
30/11/1992 46,79 46,79 43,98 43,98 -6,00% 6,00% 76.597
27/11/1992 46,79 46,79 44,92 46,79 +4,17% 4,00% 5.717
25/11/1992 44,92 47,72 44,92 44,92 +0,00% 6,25% 22.576
24/11/1992 44,92 47,72 44,92 44,92 -5,88% 6,25% 26.102
23/11/1992 50,53 50,53 44,92 47,72 -5,56% 11,11% 37.724
20/11/1992 52,40 54,27 48,66 50,53 -0,92% 10,71% 93.108
19/11/1992 48,66 52,40 45,85 51,00 +11,22% 13,46% 206.066
18/11/1992 48,66 52,40 44,92 45,85 — 15,38% 886.860